Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by MiNA Therapeutics Limited

MiNA Therapeutics Presents New Pre-Clinical Data from Sickle Cell Disease Program at the European Hematology Association 2025 Congress
From MiNA Therapeutics Limited
Via Business Wire
MiNA Therapeutics Presents New Data for its HbF Program at the Keystone Symposia’s Delivery of Nucleic Acid Therapeutics Conference
From MiNA Therapeutics Limited
Via Business Wire
MiNA Therapeutics Highlights Preclinical Research on RNA Activation (RNAa) Therapeutics Presented at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
From MiNA Therapeutics Limited
Via Business Wire
MiNA Therapeutics Presents Late-Breaking Positive Phase 1b Data for MTL-CEBPA in Combination with an Anti-PD1 Checkpoint Inhibitor at the Annual American Association of Cancer Research (AACR) Meeting
From MiNA Therapeutics Limited
Via Business Wire
First Patient Dosed in Randomised Phase 2 Clinical Trial of MTL-CEBPA in Patients with Advanced Liver Cancer
From MiNA Therapeutics Limited
Via Business Wire
MiNA Therapeutics Highlights Clinical Data Supporting the Further Development of MTL-CEBPA as an Anti-cancer Immunotherapy
From MiNA Therapeutics Limited
Via Business Wire
MiNA Therapeutics to present at Jefferies 2021 London Healthcare Conference
From MiNA Therapeutics Limited
Via Business Wire
MiNA Therapeutics Announces Equity Investment From Lilly
From MiNA Therapeutics Limited
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.